3Sridhar S C, Miranti C K. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin - dependent crosstalk with c Met receptor and Src kinases[J]. Oncogene, 2006, 25 : 2367.
4Bandyopadhyay A, Agyin J K, Wang I., et al. Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-b type 1 receptor kinase inhibilor[J ]. Cancer Research, 2006, 66: 6714.
5Potter J D. Morphogens, morphostats, microarchiteeture and malignancy[J]. Nature Reviews Cromer, 2007, 7: 464.
6Peinado H, Olmeda D, Cano A. Snail, ZEB and bHLH factors in turnout progression: An alliance against the epithelial phenotype[J]. Nature Reviews Cancer, 2007, 7: 415.
7Kallakury B V, Yang F, Figge J, et al. Decreased levels of CD44 protein and mRNA in prostate carcinoma Correlation with tumor grade and ploidy[J]. Cancer, 1996, 78: 1461.
8Kaetzel D M, Zhang Q B, Yang M M, et al. Potential roles of 3- 5- exonuclease activity of NM23 -H1 in DNA repair and maligr,ant progression [J].Journal of Bioenergeties and Bionmmbranes, 2003, 8: 163.
9Nash K T, Welch D R. The KISSI metastasis suppressor: Mechanistic insights and clinical utility[J ]. Frontiers in Bio science, 2006, 11 : 647.
10Hickson J A, Huo D, Vander Griend D J, et al. The p38 Kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma[J].Cancer Research, 2006, 66: 2264.
10YCSHIDA B A,SOKOLOFF M M,WELCH D R,et al.Metastasis-suppressor genes:a review and perspective on an emerging field[J].J Natl Cancer Inst,2000,92(21):1717-1730.
4Garcia M, Jemal A,Ward EM, et al. Global cancer facts and fig- ures 2007. Atlanta: American Cancer Society, 2007 : 25-26.
5Debies MT, Welch DR. Genetic basis of human breast cancer me- tastasis. J Mammary Gland Biol Neoplasia, 2001,6 ( 4 ) :44 ! -451.
6Lee YG, Macoska JA, Korenchuk S, et al. MIM, a potential me- tastasis suppressor gene in bladder cancer. Neoplasia,2002,4 (4) : 291-294.
7Parr C, Jiang WG. Metastasis suppressor 1 ( MTSS1 ) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur J Cancer,2009,45 (9) : 1673-1683.
8Mattila PK, Salminen M, Yamashiro T, et al. Mouse MIM, a tis- sue-specific regulator of cytoskeletal dynamics, interacts with ATP- actin monomers through its C-terminal WH2 domain. J Biol Chem, 2003,278 (10) :8452-8459.
9Ma S, Guan XY, Lee TK, et ai. Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma. Hum Patho1,2007,38 ( 8 ) : 1201-1206.
10Machesky LM, Johnston SA. MIM : a muhifunctional scaffold pro- tein. J Mol Med (Berl),2007,85(6) :569-576.
